COVID-19 may have spread faster in US because first symptom was cough.
Study by USCFounded in 1880, the University of Southern California is one of the world’s leading private research universities. It is located in the heart of Los Angeles.“>USC researchers finds that order of symptoms in first wave of COVID-19First identified in 2019 in Wuhan, China, Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has spread globally, resulting in the 2019–20 coronavirus pandemic.”>COVID-19 varied among virus strains.
The strain of COVID-19 virus that was circulating in the United States and Europe during the first wave of the pandemic may have been particularly infectious because the most common first symptom was likely a cough, according to a study led by researchers from the USC Dornsife College of Letters, Arts and Science.
The study suggests that people infected with what was the world’s most infectious strain of COVID-19 in May 2020, and the most dominant strain in the U.S. two months later, were likely to experience a cough as their first symptom, followed by fever. The research was conducted at the USC Michelson Center for Convergent Bioscience in the Convergent Science Institute in Cancer led by Peter Kuhn.
The greater transmissibility of that variant — D614G — might be explained by infected individuals coughing and spreading the virus before they were incapacitated by fever. COVID-19 is most commonly spread through respiratory droplets, often amplified by a cough of symptomatic patients.
Conversely, those infected with the COVID-19 variant during the initial outbreak in China, the Wuhan reference strain, probably experienced fever as their first symptom, followed by cough.
Studying the likely order of symptoms, in addition to how the disease spreads, can inform additional research and health care about how people experience the disease.
The study, which was published today (December 16, 2021) by PLOS Computational Biology, also noted that:
- In Japan, it’s likely a fever was the initial symptom when the Wuhan reference strain was dominant there. When the D614G variant supplanted it, a cough was likely the first symptom. This finding validates similar results from other geographical regions and supports the hypothesis that a cough occurs earlier in the D614G variant than the Wuhan reference strain.
- The predicted symptom order was not altered by region, weather, patient age, or comorbidity.
- The study did not answer the question of whether the order of symptoms found in the initial waves of the pandemic holds true for current variants.
“With the emergence of new variants and the likelihood COVID-19 becomes endemic in the population, it’s important that researchers continue to show how viral variants affect progression of symptoms and disease in individuals and populations.”
- Peter Kuhn, a dean’s professor of biological sciences and professor of biological sciences, medicine, biomedical engineering and aerospace and mechanical engineering.
“Studying the likely order of symptoms may increase our understanding of how disease spreads and further inform future research and health care on how individuals are likely to experience disease.”
- Joseph Larsen, graduate researcher at USC’s Convergent Science Institute of Cancer and doctoral candidate in USC Dornsife’s Quantitative and Computational Biology Department.
The latest findings expand on research that Kuhn and his collaborators published in August 2020 that discovered the order of symptoms from the Wuhan reference strain. The discovery was based on a mathematical model using data from an outbreak in China in early 2020.
Reference: “Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the official name of the virus strain that causes coronavirus disease (COVID-19). Previous to this name being adopted, it was commonly referred to as the 2019 novel coronavirus (2019-nCoV), the Wuhan coronavirus, or the Wuhan virus.”>SARS-CoV-2 variant” 16 December 2021, PLoS Computational Biology.
About the study
In addition to Kuhn and Larsen, study co-authors from USC Dornsife were James B. Hicks, professor (research) of biological sciences. Kuhn, Hicks and Larsen are also associated with the USC Michelson Center for Convergent Bioscience. Additional authors were Margaret Martin from Tufts University’s Department of Computer Science and John Martin at Materia Therapeutics.
Funding support came from the Hsieh Family Foundation and the Kathy & Richard Leventhal Research Fund. Larsen also had support from USC Dornsife and the Schlegel Family Endowment Fellowship.
About USC Dornsife
The USC Dornsife College of Letters, Arts and Sciences is the oldest school at the University of Southern California and works across the natural sciences, social sciences and humanities, exploring fundamental questions about who we are, how the world works, and what we can do to improve and enrich society.
About the USC Michelson Center
The USC Michelson Center for Convergent Bioscience was created to accelerate discoveries from the bench to the bedside. The physical hub of this effort is Michelson Hall, a state-of-the-art research building housing cutting edge technology platforms and the nucleus of various research programs. The Michelson Center includes researchers from USC Dornsife, the USC Viterbi School of Engineering, the Keck School of Medicine of USC, as well as the USC School of Cinematic Arts and the Information Sciences Institute.